Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?
- Resource Type
- Journal
- Source
ONCOTARGET ; NOV 2012, 3 11, p1335-p1347, 13p.- Subject
- Language
- English
- ISSN
- 19492553